These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia. Okada H; Nakanishi C; Yoshida S; Shimojima M; Yokawa J; Mori M; Tada H; Yoshimuta T; Hayashi K; Yamano T; Hanayama R; Yamagishi M; Kawashiri MA Sci Rep; 2019 Mar; 9(1):4695. PubMed ID: 30886174 [TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection. Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055 [TBL] [Abstract][Full Text] [Related]
4. Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells as a Model to Study Autosomal Recessive Hypercholesterolemia. Nikasa P; Tricot T; Mahdieh N; Baharvand H; Totonchi M; Hejazi MS; Verfaillie CM Stem Cells Dev; 2021 Jul; 30(14):714-724. PubMed ID: 33938231 [TBL] [Abstract][Full Text] [Related]
5. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia. Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484 [TBL] [Abstract][Full Text] [Related]
6. Review of the scientific evolution of gene therapy for the treatment of homozygous familial hypercholesterolaemia: past, present and future perspectives. Rodriguez-Calvo R; Masana L J Med Genet; 2019 Nov; 56(11):711-717. PubMed ID: 30877235 [TBL] [Abstract][Full Text] [Related]
12. New opportunities in the management and treatment of refractory hypercholesterolemia using in vivo CRISPR-mediated genome/base editing. Srivastava RAK Nutr Metab Cardiovasc Dis; 2023 Dec; 33(12):2317-2325. PubMed ID: 37805309 [TBL] [Abstract][Full Text] [Related]
14. A review of gene- and cell-based therapies for familial hypercholesterolemia. Hajighasemi S; Mahdavi Gorabi A; Bianconi V; Pirro M; Banach M; Ahmadi Tafti H; Reiner Ž; Sahebkar A Pharmacol Res; 2019 May; 143():119-132. PubMed ID: 30910740 [TBL] [Abstract][Full Text] [Related]
15. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship. Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735 [TBL] [Abstract][Full Text] [Related]
16. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia. Cayo MA; Cai J; DeLaForest A; Noto FK; Nagaoka M; Clark BS; Collery RF; Si-Tayeb K; Duncan SA Hepatology; 2012 Dec; 56(6):2163-71. PubMed ID: 22653811 [TBL] [Abstract][Full Text] [Related]
17. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function. Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760 [TBL] [Abstract][Full Text] [Related]
18. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system. Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152 [TBL] [Abstract][Full Text] [Related]
19. Homozygous familial hypercholesterolaemia: update on management. France M Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828 [TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia. Kassim SH; Li H; Bell P; Somanathan S; Lagor W; Jacobs F; Billheimer J; Wilson JM; Rader DJ Hum Gene Ther; 2013 Jan; 24(1):19-26. PubMed ID: 22985273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]